ArriVent BioPharma, Inc. (AVBP) vs MiMedx Group, Inc. (MDXG)
A side-by-side comparison of ArriVent BioPharma, Inc. and MiMedx Group, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AVBP
ArriVent BioPharma, Inc.
$15.09HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
MDXG
MiMedx Group, Inc.
$4.62HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — AVBP vs MDXG
growth of $100 · dividends reinvested · last 3yAVBP +42.3% (+12.5%/yr)MDXG -43.9% (-17.5%/yr)AVBP compounded faster over this window
AVBP MDXG
AVBP vs MDXG: by the numbers
- •AVBP is the larger company ($703M vs $673M market cap).
- •MDXG is profitable (1.76% net margin) while AVBP runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | AVBP | MDXG |
|---|---|---|
| P/E ratio | N/A | 115.50 |
| P/S ratio | N/A | 1.90 |
| P/B ratio | 1.92 | 3.12 |
| EV / EBITDA | N/A | 26.41 |
| FCF yield | N/A | 6.03% |
Profitability
| Metric | AVBP | MDXG |
|---|---|---|
| Gross margin | 0.00% | 78.85% |
| Operating margin | 0.00% | 15.26% |
| Net margin | 0.00% | 1.76% |
| ROE | -44.63% | 2.89% |
| ROIC | -47.96% | 1.97% |
Growth (annualized)
| Metric | AVBP | MDXG |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 6.36% |
| Total return CAGR (5Y) | N/A | -4.94% |
Frequently asked
- Is AVBP or MDXG more profitable?
- MDXG runs the higher net margin — AVBP at 0.00% versus MDXG at 1.76%.
Go deeper
Dig into the metrics
MiMedx P/E ratioArriVent BioPharma ROEMiMedx ROEArriVent BioPharma operating marginMiMedx operating marginArriVent BioPharma revenue growthMiMedx revenue growthArriVent BioPharma free cash flowMiMedx free cash flow
ArriVent BioPharma & MiMedx appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.